The report entitled The Plasma Proteins Market in the Middle East 2013 provides sales in units and dollars of all the therapeutic plasma and recombinant proteins by company in Egypt, Iran, Israel, Jordan, Kuwait, Lebanon, Saudi Arabia, Turkey and the United Arab Emirates. This report is updated approximately every three years.
As in previous reports, the sales data in this region largely reflect the results of public tenders, and in a few countries sales on a generally modest private market. The report also analyses products distribution and pricing, blood and plasma collections, plasma fractionation, hemophilia care and new product introductions.
The report is delivered electronically (Excel and pdf files) and as a hard copy. Each country chapter covers the topics listed in the table of contents of a sample country chapter below.
For more information or to order this report, please contact
The Marketing Research Bureau at firstname.lastname@example.org, or +1 203 799-0298.
THE PLASMA PROTEINS MARKET IN THE MIDDLE EAST
TABLE OF CONTENTS OF A SAMPLE COUNTRY CHAPTER
HEALTH CARE ENVIRONMENT
BLOOD AND PLASMA COLLECTIONS
INTRAMUSCULAR IMMUNE GLOBULIN MARKET
Polyvalent Intramuscular & Sub-cutaneous Immune Globulin
Tetanus Immune Globulin
Rho(D) Immune Globulin
Rabies immune Globulin
Hepatitis B Immune Globulin
Other Hyperimmune Globulin
POLYVALENT INTRAVENOUS & SUBCUTANEOUS IMMUNE GLOBULIN (IVIG) MARKET
HEMOPHILIA CARE MARKET
Demographic Data on Hemophilia
Hemophilia Care Delivery
OTHER PLASMA PRODUCTS MARKETS
REGISTRATION AND REGULATIONS
PRICING AND DISTRIBUTION
MARKET TRENDS AND THREE-YEAR FORECAST
LIST OF MAJOR COMPANIES AND ORGANIZATIONS